for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Clinigen Group PLC

CLINC.L

現在値

820.00GBp

変化

0.50(+0.06%)

出来高

268,317

本日のレンジ

810.00

 - 

829.50

52週レンジ

554.00

 - 

940.00

∙ 約20分前の相場を表示しています。

価格

前日終値
819.50
始値
829.50
出来高
268,317
3か月平均出来高
7.33
高値
829.50
安値
810.00
52週高値
940.00
52週安値
554.00
発行済株式数
133.03
時価総額
1,088.84
予想PER
13.01
配当利回り
0.93

次のエベント

Full Year 2021 Clinigen Group PLC Earnings Release

適時開示

その他

Clinigen Group Sees H1 EBITDA Of At Least £54M

Clinigen Group Says Co Signs MAP Agreement With Synairgen

Clinigen Group FY Adjusted Underlying Basic EPS Rose 20 Pct To 65.6 Pence

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Clinigen Group PLCとは

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.

業種

Major Drugs

連絡先

Pitcairn House

Crown Square, First Avenue

DE14 2WW

United Kingdom

+44.1283.495010

http://www.clinigengroup.com/

エグゼクティブリーダーシップ

Peter Vance Allen

Independent Non-Executive Chairman of the Board

Shaun Edward Chilton

Chief Executive Officer, Director

Nick Keher

Group Chief Financial Officer, Executive Director

Sam Herbert

Chief Operating Officer

Amanda Miller

General Counsel, Company Secretary

統計

1.75 mean rating - 8 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2018

0.4K

2019

0.5K

2020

0.5K

2021(E)

0.5K
EPS (GBp)

2018

44.700

2019

53.500

2020

64.600

2021(E)

62.661
株価売上高倍率(過去12カ月)
86.13
株価売上高倍率(過去12カ月)
2.10
株価純資産倍率(四半期)
2.49
株価キャッシュフロー倍率
15.51
総負債/総資本(四半期)
94.63
長期負債/資本(四半期)
93.63
投資利益率(過去12カ月)
1.49
自己資本利益率(過去12カ月)
1.25

最新ニュース

最新ニュース

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up